PHILADELPHIA ― High-frequency deep transcranial magnetic stimulation (TMS) that targets signaling pathways involved in obsessive compulsive disorder (OCD) is showing promise as a novel approach for the treatment of this challenging disorder, new research shows.
“OCD unfortunately is a very disabling disorder for many of the people who have it, and about half of patients who have OCD are not able to recover adequately with currently approved treatments,” Aron Tendler, MD, chief medical officer of BrainsWay®, told Medscape Medical News.
Read the article here.
